Correction to: Gene Therapy (2005) 12, 1070–1078. doi:10.1038/sj.gt.3302493
Since publication of the above article the authors have identified an error in Figure 5, the correct figure is shown below. The authors would like to apologize for this mistake.
Effect of an inflammation-inducible promoter on plasmid-specific gene expression. CMT-93 cells were incubated for 2 h with E. coli BM2710 / pGB2Ωinv-hly carrying either plasmid pC1ΩTGF-β1 or pC1ΩTGF-β1IND. Monolayers were then washed and cultured in complete medium for 48 additional hours. Where specified, rIL-1β (10 ng / ml), rTNFα (10 ng / ml), or LPS (10 μg / ml), was added to the culture medium. (a) RT-PCR was performed on total RNA extracted from monolayers to identify GAPDH and plasmid-specific TGF-β1 transcripts. For each condition four separate determinations were performed, a representative experiment is reported. (b) After 24 h, conditioned medium was collected and TGF-β1 level was measured by ELISA. Data represent means±s.e. of three separate experiments with triplicate determinations. *denotes P<0.01 versus control, + denotes P<0.05 versus control.
Additional information
The online version of the original article can be found at 10.1038/sj.gt.3302493
Rights and permissions
About this article
Cite this article
Castagliuolo, I., Beggiao, E., Brun, P. et al. Erratum: Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 12, 1158 (2005). https://doi.org/10.1038/sj.gt.3302574
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302574
